Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Indivior ( (GB:INDV) ) just unveiled an update.
Indivior PLC announced the repurchase and cancellation of 209,246 of its ordinary shares as part of its ongoing $100 million Share Repurchase Program. This move reduces the total number of shares with voting rights to 125,062,916, potentially impacting shareholder interests and company valuation, as the program aims to enhance shareholder value and optimize the capital structure.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing on the development and distribution of medications primarily for addiction treatment. The company is known for its products designed to address opioid dependence and other addiction issues, positioning itself as a leader in the healthcare sector focused on addiction recovery solutions.
YTD Price Performance: -22.83%
Average Trading Volume: 462,023
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.15B
For an in-depth examination of INDV stock, go to TipRanks’ Stock Analysis page.
